Stockreport

ARCA Biopharma up 141% after FDA agreement for Phase 3 trial of Gencaro [Seeking Alpha]

ARCA biopharma, Inc.  (ABIO) 
US:NASDAQ Investor Relations: arcabio.com/investors
PDF ARCA Biopharma up 141% after FDA agreement for Phase 3 trial of Gencaro [Read more]